We recently compiled a list of the 10 Best Guru Stocks To Buy Now. In this article, we will have a look at where Amicus Therapeutics, Inc. (NASDAQ:FOLD) ranks among the best guru stocks to buy now. Due to the plethora of investment options such as equities, bonds, and mutual funds that are available today, […]
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Amicus' (FOLD) lead drug, Galafold, is witnessing solid sales uptake so far. The approval for Pombiliti + Opfolda also aids sales. However, overdependence on Galafold for revenues remains a concern.